聂莉芳教授论治慢性肾衰经验及早中期慢性肾衰患者生存质量的研究
|
摘要
近年来全球范围的慢性肾脏病(chronic kidney disease,CKD)以及由此导致慢性肾功能衰竭(chronic renal failure,CRF)的发病率和患病率均明显升高,已经成为不可忽视的医疗问题和社会问题。因此,加强慢性肾衰的早期防治十分必要。从临床实践来看,在慢性肾衰的早中期,若中医药调治得当,则“可以明显地减轻甚至消除症状,不同程度地改善肾功能指标,改善生活质量及延缓肾衰进程,从而延长生命”。在慢性肾功能衰竭的中医治疗方面,通过长期临床探索和总结出来的名老中医的宝贵经验尤当值得继承、借鉴和发扬。
在运用中医治疗慢性肾功能衰竭的实践中,不可避免的要涉及疗效评价的问题。在CRF患者长期的治疗过程中除了应用临床及有关生物学指标外,若再结合与健康有关的生存质量(Health-related quality of life, HRQOL)量表联合观察治疗反应,则能较全面的评价疾病及其治疗方法对病人造成的身体、心理和社会的影响,对治疗的结果做科学的分析和评价,帮助研究者获得全面正确的结论。而在慢性肾功能衰竭生存质量研究方面,目前主要集中在肾脏替代治疗领域,关于早中期慢性肾功能衰竭患者的生存质量鲜有报道。
基于此,本文在总结导师聂莉芳教授论治慢性肾功能衰竭经验的同时,对124例早中期慢性肾功能衰竭患者的生存质量状况以及影响因素作了初步的调查分析；并以导师运用益气养阴法治疗慢性肾功能衰竭气阴两虚证的经验为基础,观察了益气养阴法对早中期慢性肾衰气阴两虚证患者近期生存质量的改善情况。本研究的创新点有二：①对早、中期慢性肾功能衰竭患者的生存质量状况以及影响因素进行横断面调查；②观察益气养阴法对早、中期慢性肾功能衰竭气阴两虚证患者生存质量的影响。
1.导师聂莉芳教授运用中医药理论论治慢性肾衰的经验
聂莉芳教授认为慢性肾衰的治疗包括治病和治人两个方面。治“病”的同时,必须考虑到患病的“人”这一因素。
聂莉芳教授在以标本缓急理论分析了慢性肾功能衰竭“错综复杂”的中医病因病机和临床表现后,提出了慢性肾衰的中医临床分期,即将慢性肾衰分为虚损期和关格期。虚损期临床表现以一派虚损症状为主,其病机特点以正气虚衰为主,气阴两虚证较为多见。关格期病机特点以邪实为主,湿浊内停是其重心。
聂莉芳教授认为慢性肾衰的中医治疗,应首辨病期,然后再辨证,将辨病期与辨证有机结合。虚损期病情相对较轻较缓,所以治疗应以缓则治本,扶助正气为主；关格期病情相对较重,所以治疗应以祛邪为主,兼顾扶正；若慢性肾衰患者病程中出现可逆因素时,则急则治标,迅速祛除可逆因素,解除病情的恶化趋势。
虚损期若辨证属脾肺气虚证,治当补益脾肺之气,方药选用补中益气汤、参苓白术散等。若辨证属脾肾阳虚证,治当温补脾肾,方药选用保元汤、真武汤等。若辨证属肝肾阴虚证,治当滋养肝肾,平肝潜阳,方药选用杞菊地黄汤、麻菊地黄汤、归芍地黄汤等。若辨证属气阴两虚证,治当益气养阴,方药选用参芪地黄汤加泽泻。相对于虚损期而言,关格期病势急骤多变,病机特点以邪实为主。其治疗,应以祛邪为主兼以扶正,要权衡标本缓急,注意护养胃气,以调理脾胃为重心。若辨证属脾胃气虚,寒湿中阻证,治当健脾益气以调理脾胃,方药选用香砂六君子汤。若辨证属湿热中阻证,治当清化湿热以调理脾胃,方药选用黄连温胆汤、苏叶黄连汤、半夏泻心汤等。若慢性肾衰患者在病程中,因可逆因素而发生外感、水肿、小便不利、水凌心肺等情况时,其治疗当以祛邪为首务,根据患者具体情况对症治疗。应注意的是,因慢性肾衰患者正气虚馁,所以在施用祛邪法则时,要注意中病即止,以免徒伤正气,变生它疾。
2.早中期慢性肾衰患者的生存质量及其影响因素研究
目的：通过横断面调查,观察早中期慢性肾功能衰竭患者的生存质量状况及其影响因素。方法：病例选择自中国中医科学院西苑医院、北京中医药大学东方医院和北京军区总医院肾内科的早中期慢性肾功能衰竭患者124例。使用中文版SF-36量表进行问卷评价患者的生存质量。用李克累加法,按最后题值计算原始分数,再用标准公式计算转换分数。用SPSS13.0软件包分析数据。结果：(1)早中期慢性肾衰患者SF-36量表各维度得分均数由低至高排列,依次为：一般健康状况(GH)：36.24±12.97；生理职能(RP)：37.74±31.20；精力(VT)：52.60±20.75；情感职能(RE)：55.34±30.06；精神健康(MH)：59.20±17.85;社会功能(SF)：59.88±18.05；生理机能(PF)：79.11±14.87,躯体疼痛(BP)：79.60±19.14。早中期慢性肾衰患者生存质量水平在生理机能(PF)、生理职能(RP)、一般健康状况(GH)、社会功能(SF)、情感职能(RE)维度得分显著低于普通人群；早中期慢性肾衰患者生存质量水平在生理机能(PF)、生理职能(RP)、躯体疼痛(BP)、一般健康状况(GH)、社会功能(SF)、情感职能(RE)维度得分显著高于血透人群。(2)影响早中期慢性肾衰患者生理因素综合得分(PCS)的因素有性别、年龄和Scr值。影响早中期慢性肾衰患者心理因素综合得分(MCS)的因素主要是文化程度。男性患者在生理职能(RP)、躯体疼痛(BP)、一般健康状况(GH)、精力(VT)、精神健康(MH)的维度得分明显高于女性患者,差异有统计学意义(P<0.05)。三个年龄段患者之间,生理机能(PF)和精力(VT)的维度得分差异有统计学意义(P<0.05),年龄段越低,得分越高。三组不同文化程度患者之间,精力(VT)和精神健康(MH)的维度得分差异有统计学意义(P<0.05),文化程度越高,得分越高。患者生存质量与Scr呈负相关,Scr越低(即eGFR越高),得分越高。eGFR为“60-89ml／min”患者在生理职能(RP)、一般健康状况(GH)、精力(VT)维度的得分明显高于eGFR为“30-59ml／min”患者的得分。结论：(1)早中期慢性肾衰患者生存质量总体水平低于普通人群。(2)影响早中期慢性肾衰患者生存质量的因素有性别、年龄、Scr值和文化程度。
3.益气养阴法对早中期慢性肾衰气阴两虚证患者生存质量影响的临床研究
目的：观察益气养阴法对早中期慢性肾衰气阴两虚证患者生存质量的影响。方法：采用平行对照的方法,将入选的57例患者分为治疗组(30例,来自中国中医科学院西苑医院)和对照组(27例,来自北京军区总医院)。对照组采用西医慢性肾脏病一体化疗法治疗,治疗组在西医对症治疗的基础上,加用益气养阴之参芪地黄汤加减治疗。应用中文版SF-36量表进行问卷评价患者的生存质量。各组患者在治疗前和治疗3个月后各测评1次。用李克累加法,按最后题值计算原始分数,再用标准公式计算转换分数。用SPSS13.0软件包分析数据。结果：治疗组患者治疗后的生理因素综合测评(PCS)、心理因素综合测评(MCS)及总体生存质量(总分)、Scr值与治疗前相比有非常显著性差异(P<0.01)。从各维度来看,治疗后精力(VT)、生理职能(RP)、一般健康状况(GH)、情感职能(RE)精神健康(MH)的得分明显高于治疗前(P<0.01或P<0.05)。经意向性分析,对照组患者治疗后的生理因素综合测评(PCS)、心理因素综合测评(MCS)及总体生存质量(总分)与治疗前相比有非常显著性差异(P<0.01)。从各维度来看,治疗后生理职能(RP)、躯体疼痛(BP)、一般健康状况(GH)、精神健康(MH)精力(VT)的得分明显高于治疗前(P<0.01或P<0.05)。经意向性分析,治疗后对照组和治疗组的生理职能(RP)维度得分有显著性差异(P<0.05),治疗组高于对照组。其余得分没有显著性差异。结论：与治疗前相比,两组治疗均对早中期慢性肾衰气阴两虚证患者近期的总体生存质量有明显的改善作用,但还不能认为两组间的治疗疗效有差别。
In recent years, the increasing incidence and prevalence rates of the chronic kidney disease(CKD) and which cause chronic renal failure(CRF) around the world, have become an overlooked medical and social problems.Therefore,it is necessary to enhance the early prevention and treatment of chronic renal failure.
In early to middle stages of chronic renal failure,if patients of CRF were treated properly by Chinese medicine,their symptoms would be reduced or even eliminated, the renal function and quality of life would be improved,thus delay the process of CRF with varying degrees. And it was very important of the clinical experience of famous experts of Chinese medicine from long-term clinical practice.
On clinical evaluation of chronic renal failure treated by Chinese medicine,based on clinical and biological indexes, the health-related quality of life(HRQOL) scale was combined,then it was more comprehensive for the effect evaluation of chronic renal failure.At present,there were lots of research on quality of life(QOL) of end-stage renal disease,but few research on early to middle stages of chronic renal failure.
Therefore, the quality of life and its related factors of 124 cases with early to middle stages of CRF was investigated.At the same time, reinforcing Qi and nourishing Yin's effect on recent quality of life of early to middle stages of CRF's patients with syndrome of dual deficiency of qi and yin was observed which based on the my tutor's clinic experience of CRF. The innovations of my paper are two aspects:①The quality of life and its related factors of patients with early to middle stages of CRF was investigated by the cross-sectional survey;②Reinforcing qi and nourishing yin's effect on recent QOL of early to middle stages of CRF's patients with syndrome of dual deficiency of qi and yin was observed.
1.My tutor's clinic experience of CRF by Chinese medicine
After analyzing the complex pathogenesis and clinical manifestations of CRF by the theory of "tip and root"and"chronic and acute",my tutor put forward the view on TCM's clinic stages of CRF,including"deficiency stage" and "block and repulsion stage".The manifestations of "deficiency stage"were lots of deficiency symptoms due to the pathogenesis of healthy qi deficiency. The pathogenesis of "block and repulsion stage"was pathogenic qi excess mainly,and internal obstruction of dampness turbidity was key.
My tutor thinked that the basic concept of treating CRF was the combination of "treating disease"and "treating person". And the basic principles of treating CRF by Chinese medicine was the combination of differentiating stages and differentiating syndromes was of very importance for the treatment of CRF by Chinese medicine.
In contrast,the condition of "deficiency stage"was mild ralatively,so the principles of therapy was mainly reinforcing healthy qi and treating the root.(1) spleen-lung qi deficiency syndrome,treated by Buzhongyiqi decoction,or Shenlingbaizhu powder preparation;(2)spleen-kidney yang deficiency syndrome,treated by Baoyuan decoction,or Zhenwu decoction;(3) liver-kidney yin deficiency syndrome,treated by Qijudihuang decoction,or Majudihuang decoction,or Guishaodihuang decoction;(4) syndrome of dual deficiency of qi and yin,treated by Shenqidihuang decoction.
The condition of block and repulsion stage"was heavier, so the principles of therapy was eliminating the pathogenic factors mainly, reinforcing healthy qi following.(1) syndrome of internal obstruction of cold-dampness,treated by Xiangshaliujunzi decoction;(2)syndrome of internal obstruction of dampness-heat,treated by Huanglianwendan decoction.
In the course of CRF,if there were reversible factors (such as external contraction,edema,urination, water qi intimidating the heart and lung),they should be treated firstly to eliminating theose factors, namely treating the tip (acute) before the root (chronic).
2. Quality of life in patients with chronic renal failure and its influencing factors
Objective:To analyze the quality of life (QOL) of patients with early to middle stages of CRF,and the influencing factors of the QOL.Methods:124 patients coming from Xiyuan Hospital of China Academy of Chinese Medical Sciences,Dongfang hospital affiliated Beijing university of TCM,the military general hospital of Bejing PLA.QOL were investigated by SF-36 health survey of Chinese version. Statistical analysis were completed by using SPSS13.0.Results:(1) The each scale's scores of SF-36 Health Survey were:GH:36.24±12.97,RP:37.74±31.20, VT:52.60±20.75,RE:55.34±30.06,MH:59.20±17.85,SF:59.88±18.05, PF:79.11±14.87,BP:79.60±19.14.They were worse than scores of general population,but higher than scores of patients with hemodialysis.(2) The influencing factors on PCS of patients with early to middle stages of CRF were gender,age and serum creatinine. The influencing factor on MCS of patients with early to middle stages of CRF was education. The influencing factor on total score of patients with early to middle stages of CRF was serum creatinine.The RP,BP,GH,VT and MH scores in male patients were higher than those in female patients.There was signifant difference(P<0.05).Among three age groups,the VT and PF scores'difference was significant (P<0.05).The age was lower,the score was higher. Among three education groups,the VT and MH scores'difference was significant (P<0.05).The education was lower, the score was higher. The scores of RP、GH、VT、PCS in stage 2 of CKD(eGFR was 60-89ml/min)were higher than those in stage 3 of CKD(eGFR was 30-59ml/min) (P<0.05 or 0.01).Conclusion:(1) The quality of life (QOL) of patients with early to middle stage of CRF was worse than general population.(2)The influencing factors were gender,age,education and Scr.
3.The research on reinforcing qi and nourishing yin's effect on recent QOL of early to middle stages of CRF's patients with syndrome of dual deficiency of qi and yin.
Objective:To evaluate the reinforcing qi and nourishing yin's effect on recent QOL of early to middle stages of CRF's patients with syndrome of dual deficiency of qi and yin.
Methods:57 cases were divided into treatment group and control group.30 cases in treatment group from Xiyuan Hospital of China Academy of Chinese Medical Sciences,and 27 cases in control group from the military general hospital of Bejing PLA.Integrated treatment of chronic kidney disease was carried out in control group.Shenqidihuang decoction was carried out in treatment group based on symptomatic treatment of western medicine.The QOL were investigated by SF-36 health survey of Chinese version before treatment and 3 months after treatment respectively. Statistical analysis were completed by using SPSS13.0.The analysis of ITT was carried out.
Results:the plan of treatment group could increase the scores of VT,RP,GH,RE and MH,and decrease the Scr.Compared with before treatment,there was a significant difference(P<0.01 or P<0.05).Thus the scores of physical component summary(PCS) and mental component summary(MCS) were increased,and compared with before treatment,there was very significantly difference(P<0.01).The plan of control group could increase the scores of VT,RP,GH,BP and MH.Compared with before treatment,there was a significant difference(P< 0.01 or P< 0.05) by ITT analysis.Thus the scores of PCS and MCS were increased,and compared with before treatment,there was very significantly difference(P<0.01) by ITT analysis.After treatment,there was no significant difference (P>0.05) except RP(P<0.05) between treatment group and control group.
Conclusion:The effect on reinforcing qi and nourishing yin based on symptomatic treatment of western medicine was significant for the recent QOL of early to middle stages of CRF's patients with syndrome of dual deficiency of qi and yin.It can improve the patients'recent QOL(includingRP、GH、VT、MH、RE).But the effect between two groups for patients'recent QOL was no significant difference.
在运用中医治疗慢性肾功能衰竭的实践中,不可避免的要涉及疗效评价的问题。在CRF患者长期的治疗过程中除了应用临床及有关生物学指标外,若再结合与健康有关的生存质量(Health-related quality of life, HRQOL)量表联合观察治疗反应,则能较全面的评价疾病及其治疗方法对病人造成的身体、心理和社会的影响,对治疗的结果做科学的分析和评价,帮助研究者获得全面正确的结论。而在慢性肾功能衰竭生存质量研究方面,目前主要集中在肾脏替代治疗领域,关于早中期慢性肾功能衰竭患者的生存质量鲜有报道。
基于此,本文在总结导师聂莉芳教授论治慢性肾功能衰竭经验的同时,对124例早中期慢性肾功能衰竭患者的生存质量状况以及影响因素作了初步的调查分析；并以导师运用益气养阴法治疗慢性肾功能衰竭气阴两虚证的经验为基础,观察了益气养阴法对早中期慢性肾衰气阴两虚证患者近期生存质量的改善情况。本研究的创新点有二：①对早、中期慢性肾功能衰竭患者的生存质量状况以及影响因素进行横断面调查；②观察益气养阴法对早、中期慢性肾功能衰竭气阴两虚证患者生存质量的影响。
1.导师聂莉芳教授运用中医药理论论治慢性肾衰的经验
聂莉芳教授认为慢性肾衰的治疗包括治病和治人两个方面。治“病”的同时,必须考虑到患病的“人”这一因素。
聂莉芳教授在以标本缓急理论分析了慢性肾功能衰竭“错综复杂”的中医病因病机和临床表现后,提出了慢性肾衰的中医临床分期,即将慢性肾衰分为虚损期和关格期。虚损期临床表现以一派虚损症状为主,其病机特点以正气虚衰为主,气阴两虚证较为多见。关格期病机特点以邪实为主,湿浊内停是其重心。
聂莉芳教授认为慢性肾衰的中医治疗,应首辨病期,然后再辨证,将辨病期与辨证有机结合。虚损期病情相对较轻较缓,所以治疗应以缓则治本,扶助正气为主；关格期病情相对较重,所以治疗应以祛邪为主,兼顾扶正；若慢性肾衰患者病程中出现可逆因素时,则急则治标,迅速祛除可逆因素,解除病情的恶化趋势。
虚损期若辨证属脾肺气虚证,治当补益脾肺之气,方药选用补中益气汤、参苓白术散等。若辨证属脾肾阳虚证,治当温补脾肾,方药选用保元汤、真武汤等。若辨证属肝肾阴虚证,治当滋养肝肾,平肝潜阳,方药选用杞菊地黄汤、麻菊地黄汤、归芍地黄汤等。若辨证属气阴两虚证,治当益气养阴,方药选用参芪地黄汤加泽泻。相对于虚损期而言,关格期病势急骤多变,病机特点以邪实为主。其治疗,应以祛邪为主兼以扶正,要权衡标本缓急,注意护养胃气,以调理脾胃为重心。若辨证属脾胃气虚,寒湿中阻证,治当健脾益气以调理脾胃,方药选用香砂六君子汤。若辨证属湿热中阻证,治当清化湿热以调理脾胃,方药选用黄连温胆汤、苏叶黄连汤、半夏泻心汤等。若慢性肾衰患者在病程中,因可逆因素而发生外感、水肿、小便不利、水凌心肺等情况时,其治疗当以祛邪为首务,根据患者具体情况对症治疗。应注意的是,因慢性肾衰患者正气虚馁,所以在施用祛邪法则时,要注意中病即止,以免徒伤正气,变生它疾。
2.早中期慢性肾衰患者的生存质量及其影响因素研究
目的：通过横断面调查,观察早中期慢性肾功能衰竭患者的生存质量状况及其影响因素。方法：病例选择自中国中医科学院西苑医院、北京中医药大学东方医院和北京军区总医院肾内科的早中期慢性肾功能衰竭患者124例。使用中文版SF-36量表进行问卷评价患者的生存质量。用李克累加法,按最后题值计算原始分数,再用标准公式计算转换分数。用SPSS13.0软件包分析数据。结果：(1)早中期慢性肾衰患者SF-36量表各维度得分均数由低至高排列,依次为：一般健康状况(GH)：36.24±12.97；生理职能(RP)：37.74±31.20；精力(VT)：52.60±20.75；情感职能(RE)：55.34±30.06；精神健康(MH)：59.20±17.85;社会功能(SF)：59.88±18.05；生理机能(PF)：79.11±14.87,躯体疼痛(BP)：79.60±19.14。早中期慢性肾衰患者生存质量水平在生理机能(PF)、生理职能(RP)、一般健康状况(GH)、社会功能(SF)、情感职能(RE)维度得分显著低于普通人群；早中期慢性肾衰患者生存质量水平在生理机能(PF)、生理职能(RP)、躯体疼痛(BP)、一般健康状况(GH)、社会功能(SF)、情感职能(RE)维度得分显著高于血透人群。(2)影响早中期慢性肾衰患者生理因素综合得分(PCS)的因素有性别、年龄和Scr值。影响早中期慢性肾衰患者心理因素综合得分(MCS)的因素主要是文化程度。男性患者在生理职能(RP)、躯体疼痛(BP)、一般健康状况(GH)、精力(VT)、精神健康(MH)的维度得分明显高于女性患者,差异有统计学意义(P<0.05)。三个年龄段患者之间,生理机能(PF)和精力(VT)的维度得分差异有统计学意义(P<0.05),年龄段越低,得分越高。三组不同文化程度患者之间,精力(VT)和精神健康(MH)的维度得分差异有统计学意义(P<0.05),文化程度越高,得分越高。患者生存质量与Scr呈负相关,Scr越低(即eGFR越高),得分越高。eGFR为“60-89ml／min”患者在生理职能(RP)、一般健康状况(GH)、精力(VT)维度的得分明显高于eGFR为“30-59ml／min”患者的得分。结论：(1)早中期慢性肾衰患者生存质量总体水平低于普通人群。(2)影响早中期慢性肾衰患者生存质量的因素有性别、年龄、Scr值和文化程度。
3.益气养阴法对早中期慢性肾衰气阴两虚证患者生存质量影响的临床研究
目的：观察益气养阴法对早中期慢性肾衰气阴两虚证患者生存质量的影响。方法：采用平行对照的方法,将入选的57例患者分为治疗组(30例,来自中国中医科学院西苑医院)和对照组(27例,来自北京军区总医院)。对照组采用西医慢性肾脏病一体化疗法治疗,治疗组在西医对症治疗的基础上,加用益气养阴之参芪地黄汤加减治疗。应用中文版SF-36量表进行问卷评价患者的生存质量。各组患者在治疗前和治疗3个月后各测评1次。用李克累加法,按最后题值计算原始分数,再用标准公式计算转换分数。用SPSS13.0软件包分析数据。结果：治疗组患者治疗后的生理因素综合测评(PCS)、心理因素综合测评(MCS)及总体生存质量(总分)、Scr值与治疗前相比有非常显著性差异(P<0.01)。从各维度来看,治疗后精力(VT)、生理职能(RP)、一般健康状况(GH)、情感职能(RE)精神健康(MH)的得分明显高于治疗前(P<0.01或P<0.05)。经意向性分析,对照组患者治疗后的生理因素综合测评(PCS)、心理因素综合测评(MCS)及总体生存质量(总分)与治疗前相比有非常显著性差异(P<0.01)。从各维度来看,治疗后生理职能(RP)、躯体疼痛(BP)、一般健康状况(GH)、精神健康(MH)精力(VT)的得分明显高于治疗前(P<0.01或P<0.05)。经意向性分析,治疗后对照组和治疗组的生理职能(RP)维度得分有显著性差异(P<0.05),治疗组高于对照组。其余得分没有显著性差异。结论：与治疗前相比,两组治疗均对早中期慢性肾衰气阴两虚证患者近期的总体生存质量有明显的改善作用,但还不能认为两组间的治疗疗效有差别。
In recent years, the increasing incidence and prevalence rates of the chronic kidney disease(CKD) and which cause chronic renal failure(CRF) around the world, have become an overlooked medical and social problems.Therefore,it is necessary to enhance the early prevention and treatment of chronic renal failure.
In early to middle stages of chronic renal failure,if patients of CRF were treated properly by Chinese medicine,their symptoms would be reduced or even eliminated, the renal function and quality of life would be improved,thus delay the process of CRF with varying degrees. And it was very important of the clinical experience of famous experts of Chinese medicine from long-term clinical practice.
On clinical evaluation of chronic renal failure treated by Chinese medicine,based on clinical and biological indexes, the health-related quality of life(HRQOL) scale was combined,then it was more comprehensive for the effect evaluation of chronic renal failure.At present,there were lots of research on quality of life(QOL) of end-stage renal disease,but few research on early to middle stages of chronic renal failure.
Therefore, the quality of life and its related factors of 124 cases with early to middle stages of CRF was investigated.At the same time, reinforcing Qi and nourishing Yin's effect on recent quality of life of early to middle stages of CRF's patients with syndrome of dual deficiency of qi and yin was observed which based on the my tutor's clinic experience of CRF. The innovations of my paper are two aspects:①The quality of life and its related factors of patients with early to middle stages of CRF was investigated by the cross-sectional survey;②Reinforcing qi and nourishing yin's effect on recent QOL of early to middle stages of CRF's patients with syndrome of dual deficiency of qi and yin was observed.
1.My tutor's clinic experience of CRF by Chinese medicine
After analyzing the complex pathogenesis and clinical manifestations of CRF by the theory of "tip and root"and"chronic and acute",my tutor put forward the view on TCM's clinic stages of CRF,including"deficiency stage" and "block and repulsion stage".The manifestations of "deficiency stage"were lots of deficiency symptoms due to the pathogenesis of healthy qi deficiency. The pathogenesis of "block and repulsion stage"was pathogenic qi excess mainly,and internal obstruction of dampness turbidity was key.
My tutor thinked that the basic concept of treating CRF was the combination of "treating disease"and "treating person". And the basic principles of treating CRF by Chinese medicine was the combination of differentiating stages and differentiating syndromes was of very importance for the treatment of CRF by Chinese medicine.
In contrast,the condition of "deficiency stage"was mild ralatively,so the principles of therapy was mainly reinforcing healthy qi and treating the root.(1) spleen-lung qi deficiency syndrome,treated by Buzhongyiqi decoction,or Shenlingbaizhu powder preparation;(2)spleen-kidney yang deficiency syndrome,treated by Baoyuan decoction,or Zhenwu decoction;(3) liver-kidney yin deficiency syndrome,treated by Qijudihuang decoction,or Majudihuang decoction,or Guishaodihuang decoction;(4) syndrome of dual deficiency of qi and yin,treated by Shenqidihuang decoction.
The condition of block and repulsion stage"was heavier, so the principles of therapy was eliminating the pathogenic factors mainly, reinforcing healthy qi following.(1) syndrome of internal obstruction of cold-dampness,treated by Xiangshaliujunzi decoction;(2)syndrome of internal obstruction of dampness-heat,treated by Huanglianwendan decoction.
In the course of CRF,if there were reversible factors (such as external contraction,edema,urination, water qi intimidating the heart and lung),they should be treated firstly to eliminating theose factors, namely treating the tip (acute) before the root (chronic).
2. Quality of life in patients with chronic renal failure and its influencing factors
Objective:To analyze the quality of life (QOL) of patients with early to middle stages of CRF,and the influencing factors of the QOL.Methods:124 patients coming from Xiyuan Hospital of China Academy of Chinese Medical Sciences,Dongfang hospital affiliated Beijing university of TCM,the military general hospital of Bejing PLA.QOL were investigated by SF-36 health survey of Chinese version. Statistical analysis were completed by using SPSS13.0.Results:(1) The each scale's scores of SF-36 Health Survey were:GH:36.24±12.97,RP:37.74±31.20, VT:52.60±20.75,RE:55.34±30.06,MH:59.20±17.85,SF:59.88±18.05, PF:79.11±14.87,BP:79.60±19.14.They were worse than scores of general population,but higher than scores of patients with hemodialysis.(2) The influencing factors on PCS of patients with early to middle stages of CRF were gender,age and serum creatinine. The influencing factor on MCS of patients with early to middle stages of CRF was education. The influencing factor on total score of patients with early to middle stages of CRF was serum creatinine.The RP,BP,GH,VT and MH scores in male patients were higher than those in female patients.There was signifant difference(P<0.05).Among three age groups,the VT and PF scores'difference was significant (P<0.05).The age was lower,the score was higher. Among three education groups,the VT and MH scores'difference was significant (P<0.05).The education was lower, the score was higher. The scores of RP、GH、VT、PCS in stage 2 of CKD(eGFR was 60-89ml/min)were higher than those in stage 3 of CKD(eGFR was 30-59ml/min) (P<0.05 or 0.01).Conclusion:(1) The quality of life (QOL) of patients with early to middle stage of CRF was worse than general population.(2)The influencing factors were gender,age,education and Scr.
3.The research on reinforcing qi and nourishing yin's effect on recent QOL of early to middle stages of CRF's patients with syndrome of dual deficiency of qi and yin.
Objective:To evaluate the reinforcing qi and nourishing yin's effect on recent QOL of early to middle stages of CRF's patients with syndrome of dual deficiency of qi and yin.
Methods:57 cases were divided into treatment group and control group.30 cases in treatment group from Xiyuan Hospital of China Academy of Chinese Medical Sciences,and 27 cases in control group from the military general hospital of Bejing PLA.Integrated treatment of chronic kidney disease was carried out in control group.Shenqidihuang decoction was carried out in treatment group based on symptomatic treatment of western medicine.The QOL were investigated by SF-36 health survey of Chinese version before treatment and 3 months after treatment respectively. Statistical analysis were completed by using SPSS13.0.The analysis of ITT was carried out.
Results:the plan of treatment group could increase the scores of VT,RP,GH,RE and MH,and decrease the Scr.Compared with before treatment,there was a significant difference(P<0.01 or P<0.05).Thus the scores of physical component summary(PCS) and mental component summary(MCS) were increased,and compared with before treatment,there was very significantly difference(P<0.01).The plan of control group could increase the scores of VT,RP,GH,BP and MH.Compared with before treatment,there was a significant difference(P< 0.01 or P< 0.05) by ITT analysis.Thus the scores of PCS and MCS were increased,and compared with before treatment,there was very significantly difference(P<0.01) by ITT analysis.After treatment,there was no significant difference (P>0.05) except RP(P<0.05) between treatment group and control group.
Conclusion:The effect on reinforcing qi and nourishing yin based on symptomatic treatment of western medicine was significant for the recent QOL of early to middle stages of CRF's patients with syndrome of dual deficiency of qi and yin.It can improve the patients'recent QOL(includingRP、GH、VT、MH、RE).But the effect between two groups for patients'recent QOL was no significant difference.
引文
[1]蒋燕.王绵之赵绍琴治疗慢性肾功能衰竭的用药经验比较[J].辽宁中医杂志,2004,31[4]：267-268.
[2]王蕾.王绵之教授治疗慢性肾功能衰竭学术思想及临床经验[J].北京中医,1999,(3)：49-50.
[3]童延清.任继学教授对慢性肾功能衰竭病因病机的认识[J].上海中医药大学学报,2004,18(1)：21-23.
[4]于敏,陈芝,刘晓玲,等.从微炎症发病机制探讨中医治疗慢性肾衰竭的思路与方法[J].中国中医急症,2009,18(4)：568-571.
[5]张雅丽,张玉梅.张琪治疗慢性肾功能衰竭的经验[J].黑龙江中医药,2003,(6)：3-4.
[6]林启展,徐大基,马育鹏.张琪治疗慢性肾功能衰竭经验[J].中医杂志,2006,47(8)：576-577.
[7]王永钧.治疗慢性肾功能衰竭实践和体会[J],浙江中医学院学报,2003,27(2)：2-3.
[8]张勉之.张大宁诊治慢性肾功能衰竭的思路与方法[J].中医杂志,2007,48(9)：846-848.
[9]徐英.张大宁治疗慢性肾功能衰竭的思路与方法[J].北京中医,2006,25(9)：536.
[10]欧阳晃平.聂莉芳治疗慢性肾功能衰竭经验[J].北京中医,2005,24(5)：272-273.
[11]聂莉芳.慢性肾衰竭的分期辨证经验与体会[J].中国中西医结合肾病杂志,2009,10(11)：941-944.
[12]许家松.方药中对慢性肾功能衰竭的理论认识和诊治经验[J].中医杂志,1991,32(10)：11-14.
[13]许家松.方药中对慢性肾功能衰竭的理论认识和诊治经验(续)[J].中医杂志,1991,32(11)：12-14.
[14]时振声.时氏中医肾脏病学[M].北京：中国医药科技出版社,1997.
[15]聂莉芳.关格病分期刍议[J].北京中医学院学报,1988,11(2)：21-23.
[16]赵静.孙伟治疗慢性肾脏病经验[J].中国中医药信息杂志,2009,16(1)：87-88.
[17]何伟明,孙伟.早中期慢性肾衰中医药证治思路探讨[J].江苏中医药,2009,41(10)：4-6.
[18]聂莉芳,欧阳晃平,韩东彦.200例慢性肾功能衰竭证候分布特点与分析[J].中医研究,2006,19(4)：29-31.
[19]孙卫卫,刘忠杰,张恩,等.慢性肾脏疾病3,4,5期中医证候学的临床研究[J].北京中医药大学学报(中医临床版),2009,16(5)：14-16.
[20]赵宇,占永立,饶向荣,等.460例慢性肾功能衰竭患者中医证候特征分析[J].中医杂志,2009,50(5)：446-448.
[21]陈一清,雷震,陈志明.慢性肾功能衰竭证治规律考辨[J].中医药学刊,2004,22(7)：1332-1333.
[22]赵东升.赵绍琴教授从邪实论治肾病的经验[J].新中医,1997,29(7)：6-7.
[23]栾蕾.慢性肾衰关乎少阳阳明[J].辽宁中医杂志,2005,32(2)：112-113.
[24]赵艳龙,任艳芸,马巧亚,等.慢性肾脏病病机之整体气机失调论[J].四川中医,2009,27(4)：17-19.
[25]李培旭,安艳秋.论气机升降与慢性肾衰竭[J].山东中医杂志,1999,18(5)：196.
[26]刘玉芹,烟建华.“命元三焦系统”与慢性肾功能衰竭的中医辨证[J].北京中医学院学报,1993,16(3)：21.
[27]时振声.慢性肾功能衰竭的诊治经验[J].中医杂志,1990,(9)：18-19
[28]聂莉芳.慢性肾功能衰竭诊断与中医治疗[M].北京：人民军医出版社,2008.
[29]朱戎.陈以平治疗慢性肾功能衰竭经验撷菁[J].辽宁中医杂志,2005,32(7)：648-650.
[30]任继学,任玺洁.虚损性肾衰论治[J].新中医,2001,33(12)：3-5
[31]郑平东.慢性肾衰竭病因病机与临证辨治[J].上海中医药大学学报,2008,22(2)：1-3.
[32]庞博,傅强.赵进喜辨治慢性肾功能不全经验[J].北京中医药,2009,28(9)：678-680.
[33]王世东,肖永华.吕仁和教授应用理气活血法治疗慢性肾功能衰竭经验[J].中华现代中西医杂志,2003,l(10)：919-920.
[34]王丽,林妍,张改华.李秀英从“郁”论治慢性肾衰竭的经验[J].北京中医药,2009,28(9)：671.
[35]张保伟.刘渡舟教授治疗慢性肾衰经验摭拾[J].中医药学刊,2004,22(4)：584.
[36]钟宏琳,李德干,蒋翎,等.补肾活血排毒方延缓慢性肾功能衰竭患者肾衰竭进程的临床研究[J].中国中医药信息杂志,2009,19(6)：17-18.
[37]李纪三,王东超.痰瘀论治慢性肾功能衰竭临床观察[J].医药论坛杂志,2009,30(5)：94-95.
[38]王丽,占永立,饶向荣,等.益气活血、利湿降浊法治疗慢性肾衰竭远期疗效分析[J].新中医,2009,41(1)：20-23.
[39]孔薇,邹燕勤.治疗慢性肾衰竭思路与方法[J].山东中医药大学学报,2000,24(6)：46.
[40]许筠.刘宝厚教授治疗慢性肾衰竭临证经验[J].中国中西医结合肾病杂志,2004,5(7)：376-378.
[41]郭锐.中药灌肠治疗慢性肾功能衰竭37例临床分析[J].中国医药导报,2009,6(17)：71-72.
[42]闫红卫,李兴云,曲秀英,等.中药保留灌肠不同插管深度治疗慢性肾功能衰竭效果比较[J].中国误诊学杂志,2008,8(4)：814-815.
[43]刘颖,曹景泉,张艳宁.针药并用治疗慢性肾衰竭48例[J].中国中西医结合肾病杂志,2002,3(s)：286-287.
[44]沈庆法.中医药治疗肾脏病的体会[J].上海中医药大学学报,2000,14(3)：28-29
[45]江英.中药离子导入治疗慢性肾衰竭疗效观察[J].护理学杂志,2006,21(9)：12-13.
[46]方积乾主编.生存质量测定方法及应用[M].北京：北京大学医学出版社,2000.
[47]郑良成,田辉荣,谢培增主编.医学生存质量评估[M].北京：军事医学科学 出版社,2005.
[48]刘凤斌,方积乾,王建华.与健康相关的生存质量和中医学[J].中国中医基础医学杂志,1999,5(10)：13-16.
[49]倪量,李峰.生存质量测评在中医药疗效评价中的应用[J].成都中医药大学学报,2008,31(2)：60-62.
[50]李鲁,王红妹,沈毅.SF-36健康调查量表中文版的研制及其性能测试[J].中华预防医学杂志,2002,36(2)：109-113.
[51]Garcia M, Rohlfs I, Vila J, et al. Comparison between telephone and self-administration of Short Form Health Survey Questionnaire (SF-36). Gac Sanit,2005,19(6):433-439.
[52]范仲珍,袁浩斌,胡雁,等.行为医学量表手册[M].中华医学电子音像出版社,2005：152-154.
[53]Merkus M P, Jager K J, Dekker F W, et al. The necosad study group-quality of life in patients on chronic dialysis:self-assessment 3 months after the start of treatment [J]. Am J Kidney Dis,1997,29 (4):584-592.
[54]Callahan M B. Using quality of life measurement to enhance interdisciplinary collaboration [J]. Adv Ren Replace Ther,2001, 8.(2):148-151.
[55]Curtin R B, Lowrie E G, deOreo P B. Self-reported functional status: an important predictor of health outcomes among end-stage renal disease patients [J]. Adv Ren Replace Ther,1999,6(2):133-140.
[56]Callahan M B, LeSage L, Johnstone S. A model for patient participation in quality of life measurement to improve rehabilitation outcomes[J]. Nephrol News Issues,1999,13(1):33-37.
[57]吴修荣,张元云,孙文静,等.影响尿毒症患者生存质量的因素及对策[J].山东医药,2004,44(32)：14-15.
[58]钟小仕,刘岩,卢智,等.血液透析和腹膜透析患者生存质量的评估及对比[J].广东医学,2004,25(7)：807-809.
[59]费剑英,吴明证.维持性腹膜透析患者的生活质量及其影响因素分析[J].浙 江临床医学,2008(8)：1037-1038.
[60]陈玮玲,蔡迅,黄仲良,等.腹膜透析患者的抑郁情况及影响因素分析[J].中国现代医学杂志,2006,16(19)：2976-2978.
[61]褚梅容,黄秋影,叶德琴.腹膜透析患者焦虑心理状况调查及对策[J].现代临床护理,2008,7(3)：4-6.
[62]马祖等,郑智华,张涤华,等.血液透析患者生存质量的多中心研究[J].中国血液净化,2004,3(7)：380-385.
[63]赵学伟,王亮,周焕芝,等.单中心长期血液透析人群生活质量横断面研究[J].中国血液净化,2005,4(11)：597-600.
[64]曾爱莲,谢小华,何永成,等.维持性血液透析患者生存质量及影响因素分析[J].河北医学,2006,12(5)：411-413.
[65]董静静,顾沛,陈利群,等.肾移植病人生活质量现状与影响因素分析[J].护理研究,2009,23(6)：1411-1414.
[66]郭海燕.慢性肾功能衰竭患者中医证型及其生存质量的初步调查分析[D].中山大学硕士学位论文,2004.
[67]Mendelssohn D C, Mullaney S R, Jung B, et al. What do American nephologists think about dialysis modality selection [J]. Am J Kidney Dis,2001,37(1):22-29.
[68]ebollo P, Ortega F, Baltar J M, et al. Health related quality of life (HRQOL) of kidney transplanted patients:variables that influence it [J]. Clin Transplant,2000,14(3):199-207.
[69]文吉秋,汪华林,潘光辉.血液透析和肾移植患者的生存质量比较[J].现代临床医学生物工程学杂志,2005,11(3)：193-195.
[70]罗斌,陈民,杨斌.肾替代治疗的生存质量研究[J].海南医学,2004,15(10)：8-9,5.
[71]陈民,樊均明,李正,等.肾替代治疗的前瞻性生存质量研究[J].中国中西医结合肾病杂志,2005,6(11)：639-643.
[72]张庆芳,任野平,刘畅,等.不同血液净化方式与尿毒症患者生存质量的关系[J].中国血液净化,2006,5(1)：10-12.
[73]多景华.高通量血液透析对维持性血液透析病人生存质量的影响的探讨[J].健康大视野：医学分册,2007,1：13-14.
[74]李涌泉,张欣洲.不同透析剂量对CAPD患者生存质量的影响[J].临床肾脏病杂志,2007,7(1)：8-10.
[75]牟新,张丽芬,白云静,等.止消通脉宁颗粒对糖尿病肾病肾功能不全患者生存质量的影响[J].山东中医药大学学报,2005,29(5)：355-358.
[76]张丽芬,吕仁和,赵进喜,等.中医辨证治疗方案对糖尿病肾病肾功能不全患者生存质量的影响——多中心临床研究[J].中医杂志,2008,49(2)：119-123.
[77]宋军.补肾活血法改善肾性骨病患者中医证候学及生存质量的研究[D].中国中医科学院硕士研究生学位论文,2005.
[78]姜敏敏,李鲁.血液透析患者生活质量的影响因素[J].浙江大学学报(医学版),2004,33(6)：546-549,560.
[79]师素芳,汪涛.影响腹膜透析患者社会回归因素的分析[J].中国康复医学杂志,2005,20(2)：112-115.
[80]hillips L, Davies S J, Russell G I. Functional status of CAPD patients and their mood state, dialysis dose, comorbidity and quality of life [J]. EDTNA ERCA J,1996,22(3):11-14.
[81]Keogh A M, Feehally J. A quantitative study comparing adjustment and acceptance of illness in adults on renal replacement therapy [J]. ANNA J,1999,26(5):471-477.
[82]彭文,付文成,叶朝阳,等. 维持性血液透析患者肾性贫血与健康相关生存质量[J].上海医学,2006,29(9)：648-650.
[83]王环,梅晓蓉,林小敏.维持型血液透析患者睡眠质量状况调查及相关因素分析[J].中国中西医结合肾病杂志,2010,11(3)：251-252.
[84]洪涛,刘华峰.慢性肾衰患者的生存质量及其影响因素[J].国外医学泌尿系统分册,2005,25(2)：275-280.
[85]洪海兰,王莲凤,黄冬玲,等.不同年龄维持性血液透析患者健康相关生活质量分析[J].解放军护理杂志,2009,26(7A)：28-30.
[86]冯志踽,蔡茜虹.终末期肾脏病患者心理分析与临床治疗研究[J].广东医学,2005,26(6)：804-805.
[87]石斌娅,杜鹏,孙建国.肾移植前心理状况对移植后生存质量的影响及护理对策[J].实用医学杂志,2008,(23)：4135-4137.
[88]AnneB. Bakewell, Rob M. Higgins, andMairE. Edmunds Quality of life in peritoneal dialysis patients:Decline over time and assocition with clinical outcomes[J]. Kidney Int,2002,61(1):239-248.
[89]LawsRA, Tapsell LC, Kelly J. Nutritional status and its relationship to quality of life in a sample of chronic hemodialysis[J]. J Ren Nutr, 2000,10(3):139-147.
[90]郑智华,马祖等,张涤华,等.血液透析患者营养状态与生存质量关系研究[J].中国血液净化,2005,4(4)：187-190.
[91]吴雪,冯美丽,娄凤兰,等.认知行为干预对维持性血液透析患者生活质量的影响[J].中华护理杂志,2006,41(8)：715-717.
[92]王爱平,马金萍.中国血液透析患者的自我管理行为和健康相关生活质量[J].中国临床康复,2005,9(11)：192-194.
[93]王爱平,苏兰若.血液透析患者自我管理效能和健康相关生活质量的研究[J].中国行为医学科学,2008,17(4)：316-317.
[94]赵海平,王健.血液透析患者的社会支持和希望[J].中华护理杂志,2000,5(35)：306.
[95]张静平,刘华容.家庭支持对血液透析病人生活质量的影响[J].湖南医科大学学报,2001,26(4)：359.
[96]黄秀凤,黄秀丽,白满.健康教育对尿毒症血透患者生存质量影响的研究[J].护士进修杂志,2004,19(1)：70-72.
[97]王正荣.家庭康复指导对慢性肾功能衰竭血液透析患者生存质量的影响[J].中医临床康复,2002,6(17)：2628-2629.
[98]张路霞,左力,徐国宾,等.北京市石景山地区中老年人群中慢性肾脏病的流行病学研究[J].中华肾脏病杂志,2006,22(2)：67-71.
[99]陈崴,王辉,董秀清,等.广州市城区普通人群中慢性肾脏病流行病学研究[J]. 中华肾脏病杂志,2007,23(3)：147-151.
[100]黄燕萍,王伟铭,裴道灵,等.上海城市社区成年人群慢性肾脏病流行病学研究[J].中华肾脏病杂志,2008,24(12)：872-877.
[101]刘东伟,刘章锁,胡晓舟,等.郑州市城区成年人慢性肾脏病流行病学调查[J].中华肾脏病杂志,2008,24(9)：603-607.
[102]郭兰中,张路霞,王晓刚,等.浙江省某乡村慢性肾脏病流行病学研究[J].中华肾脏病杂志,2007,23(3)：152-156.
[103]罗洋,谌贻璞,李文歌,等.云南省西双版纳地区成人慢性肾脏病流行病学调查[J].中华肾脏病杂志,2008,24(9)：609-613.
[104]迪力木拉提,李增录,刘健,等.新疆墨玉县农村维吾尔族成人慢性肾脏病流行病学调查[J].中华肾脏病杂志,2009,25(8)：607-612.
[105]廖蕴华,潘玲,陈青云,等.广西贺州城镇成人慢性肾脏病的流行病学调查[J].中华肾脏病杂志,2008,24(10)：701-705.
[106]李瑛,周乐天,刘伏友,等.湖南省长沙县慢性肾脏病的流行病学研究[J].中华肾脏病杂志,2010,26(1)：9-14.
[107]温继兰,王凤仙,李秉程,等.山西省右玉县城镇成人慢性肾脏病的流行病学研究[J].中华肾脏病杂志,2010,26(2)：99-104.
[108]王海燕主编.肾脏病学[M].第3版.北京：人民卫生出版社.2008.
[109]叶任高,李幼姬,刘冠贤主编.临床肾脏病学[M].北京：人民卫生出版社.2007.
[110]黎磊石,刘志红主编.中国肾脏病学[M].北京：人民军医出版社.2008.
[111]聂莉芳.慢性肾功能衰竭诊断与中医治疗[M].北京：人民军医出版社,2008.
[112]聂莉芳.关格病分期刍议[J].北京中医学院学报,1988,11(2)：21-23.
[113]美国NKF-K/DOQI工作组原著,王海燕,王梅主译.慢性肾脏病及透析的临床实践指南(附评述)[M].北京：人民卫生出版社,2003.
[114]陈晓农,潘晓霞,朱杰,等.早中期慢性肾功能衰竭的危险因素分析[J].诊断学理论与实践,2007,6(6)：513-518.
[115]Ma YC, Zuo L, Chen JH, et al.Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease[J]. J Am Soc Nephrol,2006,17:2937-2944.
[116]王红妹,李鲁,沈毅.中文版SF-36量表用于杭州市区居民生命质量研究[J].中华预防医学杂志,2001,35(6)：428-430.
[117]李宁秀,刘朝杰,李俊,等.四川省城乡居民SF-36评价参考值[J].华西医科大学学报,2001,31(1)：43-47.
[118]马祖等,郑智华,张涤华,等.血液透析患者生存质量的多中心研究[J].中国血液净化,2004,3(7)：380-385.
[119]邓冰,王凤,庹安军.西部内陆与沿海地区中年人群生存质量及影响因素的比较分析[J].贵州医药,2006,30(3)：205-207.
[120]王丽娟,秦小燕.肾病专科患者SCL-90测评结果分析[J].南方护理学报,2000，7(2)：49-50.
[121]钟萍,王云甫,黄朝芬,等.SCL-90对慢性肾功能不全患者的测评分析[J].健康心理学杂志,2002,10(2)：83-84.
[122]Lowrie EG, Zhang H, LePain N, et al. The association of SF-36 quality of life scales with patient mortality[J]. CQ1 Memorandum, Fresenius Medical Care,1997
[123]李鹃,王宏.重庆市区居民生命质量及其影响因素分析[J].卫生研究,2009,38(3)：329-331.
[124]黄小姝,张英,张黎民,等.武汉地区维持性血液透析患者生活质量及影响因素[J].中华肾脏病杂志,2005,21(2)：88-89.
[125]郑筱萸主编.中药新药临床研究指导原则(试行)[M].北京：中国医药科技出版社,2002.
[2]王蕾.王绵之教授治疗慢性肾功能衰竭学术思想及临床经验[J].北京中医,1999,(3)：49-50.
[3]童延清.任继学教授对慢性肾功能衰竭病因病机的认识[J].上海中医药大学学报,2004,18(1)：21-23.
[4]于敏,陈芝,刘晓玲,等.从微炎症发病机制探讨中医治疗慢性肾衰竭的思路与方法[J].中国中医急症,2009,18(4)：568-571.
[5]张雅丽,张玉梅.张琪治疗慢性肾功能衰竭的经验[J].黑龙江中医药,2003,(6)：3-4.
[6]林启展,徐大基,马育鹏.张琪治疗慢性肾功能衰竭经验[J].中医杂志,2006,47(8)：576-577.
[7]王永钧.治疗慢性肾功能衰竭实践和体会[J],浙江中医学院学报,2003,27(2)：2-3.
[8]张勉之.张大宁诊治慢性肾功能衰竭的思路与方法[J].中医杂志,2007,48(9)：846-848.
[9]徐英.张大宁治疗慢性肾功能衰竭的思路与方法[J].北京中医,2006,25(9)：536.
[10]欧阳晃平.聂莉芳治疗慢性肾功能衰竭经验[J].北京中医,2005,24(5)：272-273.
[11]聂莉芳.慢性肾衰竭的分期辨证经验与体会[J].中国中西医结合肾病杂志,2009,10(11)：941-944.
[12]许家松.方药中对慢性肾功能衰竭的理论认识和诊治经验[J].中医杂志,1991,32(10)：11-14.
[13]许家松.方药中对慢性肾功能衰竭的理论认识和诊治经验(续)[J].中医杂志,1991,32(11)：12-14.
[14]时振声.时氏中医肾脏病学[M].北京：中国医药科技出版社,1997.
[15]聂莉芳.关格病分期刍议[J].北京中医学院学报,1988,11(2)：21-23.
[16]赵静.孙伟治疗慢性肾脏病经验[J].中国中医药信息杂志,2009,16(1)：87-88.
[17]何伟明,孙伟.早中期慢性肾衰中医药证治思路探讨[J].江苏中医药,2009,41(10)：4-6.
[18]聂莉芳,欧阳晃平,韩东彦.200例慢性肾功能衰竭证候分布特点与分析[J].中医研究,2006,19(4)：29-31.
[19]孙卫卫,刘忠杰,张恩,等.慢性肾脏疾病3,4,5期中医证候学的临床研究[J].北京中医药大学学报(中医临床版),2009,16(5)：14-16.
[20]赵宇,占永立,饶向荣,等.460例慢性肾功能衰竭患者中医证候特征分析[J].中医杂志,2009,50(5)：446-448.
[21]陈一清,雷震,陈志明.慢性肾功能衰竭证治规律考辨[J].中医药学刊,2004,22(7)：1332-1333.
[22]赵东升.赵绍琴教授从邪实论治肾病的经验[J].新中医,1997,29(7)：6-7.
[23]栾蕾.慢性肾衰关乎少阳阳明[J].辽宁中医杂志,2005,32(2)：112-113.
[24]赵艳龙,任艳芸,马巧亚,等.慢性肾脏病病机之整体气机失调论[J].四川中医,2009,27(4)：17-19.
[25]李培旭,安艳秋.论气机升降与慢性肾衰竭[J].山东中医杂志,1999,18(5)：196.
[26]刘玉芹,烟建华.“命元三焦系统”与慢性肾功能衰竭的中医辨证[J].北京中医学院学报,1993,16(3)：21.
[27]时振声.慢性肾功能衰竭的诊治经验[J].中医杂志,1990,(9)：18-19
[28]聂莉芳.慢性肾功能衰竭诊断与中医治疗[M].北京：人民军医出版社,2008.
[29]朱戎.陈以平治疗慢性肾功能衰竭经验撷菁[J].辽宁中医杂志,2005,32(7)：648-650.
[30]任继学,任玺洁.虚损性肾衰论治[J].新中医,2001,33(12)：3-5
[31]郑平东.慢性肾衰竭病因病机与临证辨治[J].上海中医药大学学报,2008,22(2)：1-3.
[32]庞博,傅强.赵进喜辨治慢性肾功能不全经验[J].北京中医药,2009,28(9)：678-680.
[33]王世东,肖永华.吕仁和教授应用理气活血法治疗慢性肾功能衰竭经验[J].中华现代中西医杂志,2003,l(10)：919-920.
[34]王丽,林妍,张改华.李秀英从“郁”论治慢性肾衰竭的经验[J].北京中医药,2009,28(9)：671.
[35]张保伟.刘渡舟教授治疗慢性肾衰经验摭拾[J].中医药学刊,2004,22(4)：584.
[36]钟宏琳,李德干,蒋翎,等.补肾活血排毒方延缓慢性肾功能衰竭患者肾衰竭进程的临床研究[J].中国中医药信息杂志,2009,19(6)：17-18.
[37]李纪三,王东超.痰瘀论治慢性肾功能衰竭临床观察[J].医药论坛杂志,2009,30(5)：94-95.
[38]王丽,占永立,饶向荣,等.益气活血、利湿降浊法治疗慢性肾衰竭远期疗效分析[J].新中医,2009,41(1)：20-23.
[39]孔薇,邹燕勤.治疗慢性肾衰竭思路与方法[J].山东中医药大学学报,2000,24(6)：46.
[40]许筠.刘宝厚教授治疗慢性肾衰竭临证经验[J].中国中西医结合肾病杂志,2004,5(7)：376-378.
[41]郭锐.中药灌肠治疗慢性肾功能衰竭37例临床分析[J].中国医药导报,2009,6(17)：71-72.
[42]闫红卫,李兴云,曲秀英,等.中药保留灌肠不同插管深度治疗慢性肾功能衰竭效果比较[J].中国误诊学杂志,2008,8(4)：814-815.
[43]刘颖,曹景泉,张艳宁.针药并用治疗慢性肾衰竭48例[J].中国中西医结合肾病杂志,2002,3(s)：286-287.
[44]沈庆法.中医药治疗肾脏病的体会[J].上海中医药大学学报,2000,14(3)：28-29
[45]江英.中药离子导入治疗慢性肾衰竭疗效观察[J].护理学杂志,2006,21(9)：12-13.
[46]方积乾主编.生存质量测定方法及应用[M].北京：北京大学医学出版社,2000.
[47]郑良成,田辉荣,谢培增主编.医学生存质量评估[M].北京：军事医学科学 出版社,2005.
[48]刘凤斌,方积乾,王建华.与健康相关的生存质量和中医学[J].中国中医基础医学杂志,1999,5(10)：13-16.
[49]倪量,李峰.生存质量测评在中医药疗效评价中的应用[J].成都中医药大学学报,2008,31(2)：60-62.
[50]李鲁,王红妹,沈毅.SF-36健康调查量表中文版的研制及其性能测试[J].中华预防医学杂志,2002,36(2)：109-113.
[51]Garcia M, Rohlfs I, Vila J, et al. Comparison between telephone and self-administration of Short Form Health Survey Questionnaire (SF-36). Gac Sanit,2005,19(6):433-439.
[52]范仲珍,袁浩斌,胡雁,等.行为医学量表手册[M].中华医学电子音像出版社,2005：152-154.
[53]Merkus M P, Jager K J, Dekker F W, et al. The necosad study group-quality of life in patients on chronic dialysis:self-assessment 3 months after the start of treatment [J]. Am J Kidney Dis,1997,29 (4):584-592.
[54]Callahan M B. Using quality of life measurement to enhance interdisciplinary collaboration [J]. Adv Ren Replace Ther,2001, 8.(2):148-151.
[55]Curtin R B, Lowrie E G, deOreo P B. Self-reported functional status: an important predictor of health outcomes among end-stage renal disease patients [J]. Adv Ren Replace Ther,1999,6(2):133-140.
[56]Callahan M B, LeSage L, Johnstone S. A model for patient participation in quality of life measurement to improve rehabilitation outcomes[J]. Nephrol News Issues,1999,13(1):33-37.
[57]吴修荣,张元云,孙文静,等.影响尿毒症患者生存质量的因素及对策[J].山东医药,2004,44(32)：14-15.
[58]钟小仕,刘岩,卢智,等.血液透析和腹膜透析患者生存质量的评估及对比[J].广东医学,2004,25(7)：807-809.
[59]费剑英,吴明证.维持性腹膜透析患者的生活质量及其影响因素分析[J].浙 江临床医学,2008(8)：1037-1038.
[60]陈玮玲,蔡迅,黄仲良,等.腹膜透析患者的抑郁情况及影响因素分析[J].中国现代医学杂志,2006,16(19)：2976-2978.
[61]褚梅容,黄秋影,叶德琴.腹膜透析患者焦虑心理状况调查及对策[J].现代临床护理,2008,7(3)：4-6.
[62]马祖等,郑智华,张涤华,等.血液透析患者生存质量的多中心研究[J].中国血液净化,2004,3(7)：380-385.
[63]赵学伟,王亮,周焕芝,等.单中心长期血液透析人群生活质量横断面研究[J].中国血液净化,2005,4(11)：597-600.
[64]曾爱莲,谢小华,何永成,等.维持性血液透析患者生存质量及影响因素分析[J].河北医学,2006,12(5)：411-413.
[65]董静静,顾沛,陈利群,等.肾移植病人生活质量现状与影响因素分析[J].护理研究,2009,23(6)：1411-1414.
[66]郭海燕.慢性肾功能衰竭患者中医证型及其生存质量的初步调查分析[D].中山大学硕士学位论文,2004.
[67]Mendelssohn D C, Mullaney S R, Jung B, et al. What do American nephologists think about dialysis modality selection [J]. Am J Kidney Dis,2001,37(1):22-29.
[68]ebollo P, Ortega F, Baltar J M, et al. Health related quality of life (HRQOL) of kidney transplanted patients:variables that influence it [J]. Clin Transplant,2000,14(3):199-207.
[69]文吉秋,汪华林,潘光辉.血液透析和肾移植患者的生存质量比较[J].现代临床医学生物工程学杂志,2005,11(3)：193-195.
[70]罗斌,陈民,杨斌.肾替代治疗的生存质量研究[J].海南医学,2004,15(10)：8-9,5.
[71]陈民,樊均明,李正,等.肾替代治疗的前瞻性生存质量研究[J].中国中西医结合肾病杂志,2005,6(11)：639-643.
[72]张庆芳,任野平,刘畅,等.不同血液净化方式与尿毒症患者生存质量的关系[J].中国血液净化,2006,5(1)：10-12.
[73]多景华.高通量血液透析对维持性血液透析病人生存质量的影响的探讨[J].健康大视野：医学分册,2007,1：13-14.
[74]李涌泉,张欣洲.不同透析剂量对CAPD患者生存质量的影响[J].临床肾脏病杂志,2007,7(1)：8-10.
[75]牟新,张丽芬,白云静,等.止消通脉宁颗粒对糖尿病肾病肾功能不全患者生存质量的影响[J].山东中医药大学学报,2005,29(5)：355-358.
[76]张丽芬,吕仁和,赵进喜,等.中医辨证治疗方案对糖尿病肾病肾功能不全患者生存质量的影响——多中心临床研究[J].中医杂志,2008,49(2)：119-123.
[77]宋军.补肾活血法改善肾性骨病患者中医证候学及生存质量的研究[D].中国中医科学院硕士研究生学位论文,2005.
[78]姜敏敏,李鲁.血液透析患者生活质量的影响因素[J].浙江大学学报(医学版),2004,33(6)：546-549,560.
[79]师素芳,汪涛.影响腹膜透析患者社会回归因素的分析[J].中国康复医学杂志,2005,20(2)：112-115.
[80]hillips L, Davies S J, Russell G I. Functional status of CAPD patients and their mood state, dialysis dose, comorbidity and quality of life [J]. EDTNA ERCA J,1996,22(3):11-14.
[81]Keogh A M, Feehally J. A quantitative study comparing adjustment and acceptance of illness in adults on renal replacement therapy [J]. ANNA J,1999,26(5):471-477.
[82]彭文,付文成,叶朝阳,等. 维持性血液透析患者肾性贫血与健康相关生存质量[J].上海医学,2006,29(9)：648-650.
[83]王环,梅晓蓉,林小敏.维持型血液透析患者睡眠质量状况调查及相关因素分析[J].中国中西医结合肾病杂志,2010,11(3)：251-252.
[84]洪涛,刘华峰.慢性肾衰患者的生存质量及其影响因素[J].国外医学泌尿系统分册,2005,25(2)：275-280.
[85]洪海兰,王莲凤,黄冬玲,等.不同年龄维持性血液透析患者健康相关生活质量分析[J].解放军护理杂志,2009,26(7A)：28-30.
[86]冯志踽,蔡茜虹.终末期肾脏病患者心理分析与临床治疗研究[J].广东医学,2005,26(6)：804-805.
[87]石斌娅,杜鹏,孙建国.肾移植前心理状况对移植后生存质量的影响及护理对策[J].实用医学杂志,2008,(23)：4135-4137.
[88]AnneB. Bakewell, Rob M. Higgins, andMairE. Edmunds Quality of life in peritoneal dialysis patients:Decline over time and assocition with clinical outcomes[J]. Kidney Int,2002,61(1):239-248.
[89]LawsRA, Tapsell LC, Kelly J. Nutritional status and its relationship to quality of life in a sample of chronic hemodialysis[J]. J Ren Nutr, 2000,10(3):139-147.
[90]郑智华,马祖等,张涤华,等.血液透析患者营养状态与生存质量关系研究[J].中国血液净化,2005,4(4)：187-190.
[91]吴雪,冯美丽,娄凤兰,等.认知行为干预对维持性血液透析患者生活质量的影响[J].中华护理杂志,2006,41(8)：715-717.
[92]王爱平,马金萍.中国血液透析患者的自我管理行为和健康相关生活质量[J].中国临床康复,2005,9(11)：192-194.
[93]王爱平,苏兰若.血液透析患者自我管理效能和健康相关生活质量的研究[J].中国行为医学科学,2008,17(4)：316-317.
[94]赵海平,王健.血液透析患者的社会支持和希望[J].中华护理杂志,2000,5(35)：306.
[95]张静平,刘华容.家庭支持对血液透析病人生活质量的影响[J].湖南医科大学学报,2001,26(4)：359.
[96]黄秀凤,黄秀丽,白满.健康教育对尿毒症血透患者生存质量影响的研究[J].护士进修杂志,2004,19(1)：70-72.
[97]王正荣.家庭康复指导对慢性肾功能衰竭血液透析患者生存质量的影响[J].中医临床康复,2002,6(17)：2628-2629.
[98]张路霞,左力,徐国宾,等.北京市石景山地区中老年人群中慢性肾脏病的流行病学研究[J].中华肾脏病杂志,2006,22(2)：67-71.
[99]陈崴,王辉,董秀清,等.广州市城区普通人群中慢性肾脏病流行病学研究[J]. 中华肾脏病杂志,2007,23(3)：147-151.
[100]黄燕萍,王伟铭,裴道灵,等.上海城市社区成年人群慢性肾脏病流行病学研究[J].中华肾脏病杂志,2008,24(12)：872-877.
[101]刘东伟,刘章锁,胡晓舟,等.郑州市城区成年人慢性肾脏病流行病学调查[J].中华肾脏病杂志,2008,24(9)：603-607.
[102]郭兰中,张路霞,王晓刚,等.浙江省某乡村慢性肾脏病流行病学研究[J].中华肾脏病杂志,2007,23(3)：152-156.
[103]罗洋,谌贻璞,李文歌,等.云南省西双版纳地区成人慢性肾脏病流行病学调查[J].中华肾脏病杂志,2008,24(9)：609-613.
[104]迪力木拉提,李增录,刘健,等.新疆墨玉县农村维吾尔族成人慢性肾脏病流行病学调查[J].中华肾脏病杂志,2009,25(8)：607-612.
[105]廖蕴华,潘玲,陈青云,等.广西贺州城镇成人慢性肾脏病的流行病学调查[J].中华肾脏病杂志,2008,24(10)：701-705.
[106]李瑛,周乐天,刘伏友,等.湖南省长沙县慢性肾脏病的流行病学研究[J].中华肾脏病杂志,2010,26(1)：9-14.
[107]温继兰,王凤仙,李秉程,等.山西省右玉县城镇成人慢性肾脏病的流行病学研究[J].中华肾脏病杂志,2010,26(2)：99-104.
[108]王海燕主编.肾脏病学[M].第3版.北京：人民卫生出版社.2008.
[109]叶任高,李幼姬,刘冠贤主编.临床肾脏病学[M].北京：人民卫生出版社.2007.
[110]黎磊石,刘志红主编.中国肾脏病学[M].北京：人民军医出版社.2008.
[111]聂莉芳.慢性肾功能衰竭诊断与中医治疗[M].北京：人民军医出版社,2008.
[112]聂莉芳.关格病分期刍议[J].北京中医学院学报,1988,11(2)：21-23.
[113]美国NKF-K/DOQI工作组原著,王海燕,王梅主译.慢性肾脏病及透析的临床实践指南(附评述)[M].北京：人民卫生出版社,2003.
[114]陈晓农,潘晓霞,朱杰,等.早中期慢性肾功能衰竭的危险因素分析[J].诊断学理论与实践,2007,6(6)：513-518.
[115]Ma YC, Zuo L, Chen JH, et al.Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease[J]. J Am Soc Nephrol,2006,17:2937-2944.
[116]王红妹,李鲁,沈毅.中文版SF-36量表用于杭州市区居民生命质量研究[J].中华预防医学杂志,2001,35(6)：428-430.
[117]李宁秀,刘朝杰,李俊,等.四川省城乡居民SF-36评价参考值[J].华西医科大学学报,2001,31(1)：43-47.
[118]马祖等,郑智华,张涤华,等.血液透析患者生存质量的多中心研究[J].中国血液净化,2004,3(7)：380-385.
[119]邓冰,王凤,庹安军.西部内陆与沿海地区中年人群生存质量及影响因素的比较分析[J].贵州医药,2006,30(3)：205-207.
[120]王丽娟,秦小燕.肾病专科患者SCL-90测评结果分析[J].南方护理学报,2000，7(2)：49-50.
[121]钟萍,王云甫,黄朝芬,等.SCL-90对慢性肾功能不全患者的测评分析[J].健康心理学杂志,2002,10(2)：83-84.
[122]Lowrie EG, Zhang H, LePain N, et al. The association of SF-36 quality of life scales with patient mortality[J]. CQ1 Memorandum, Fresenius Medical Care,1997
[123]李鹃,王宏.重庆市区居民生命质量及其影响因素分析[J].卫生研究,2009,38(3)：329-331.
[124]黄小姝,张英,张黎民,等.武汉地区维持性血液透析患者生活质量及影响因素[J].中华肾脏病杂志,2005,21(2)：88-89.
[125]郑筱萸主编.中药新药临床研究指导原则(试行)[M].北京：中国医药科技出版社,2002.